TERPENOLOLO, Biophysical Neuromodulation Through State- Dependent Thermodynamic Regulation of Neuronal Function: Scientific Evidence, Human Electrodermal Correlates and Focused Directions for Mechanistic Consolidation

Terpenolol is an engineered, high- shear dispersed aqueous formulation containing cannabidiol (CBD), medium- chain triglycerides (MCT), sunflower- seed lecithin, and purified water, produced via controlled high- energy, high- shear mechanical processing. The formulation was previously described as a nanomicellar, hydrophilic CBD -derived system (Scrimali, 2026c). The present article integrates published membrane- biophysics and ion- channel evidence with Terpenolol- specific human electrodermal observations to evaluate the hypothesis that biophysical membrane modulation represents a central mechanistic component of Terpenolol neuromodulation. The contemporary literature establishes that CBD partitions into lipid bilayers, modifies membrane physical properties, and modulates voltage- gated sodium channels (Nav) through mechanisms that encompass both direct protein interactions and a parallel, bilayer- mediated component. Separately, primary bilayer studies demonstrate that alterations in bilayer elasticity can regulate sodium- channel inactivation and use- dependent current behavior. Preliminary analysis of completed, Terpenolol- specific unpublished observations suggests a baseline- dependent electrodermal pattern, with a reduction when initial autonomic activation is elevated and substantially smaller change within physiological baseline conditions. These findings do not exclude CBD polypharmacology or direct channel binding. Rather, they support a convergent model in which membrane- mediated modulation constitutes one central component of the formulation’s neuromodulatory action. Two focused studies are proposed to consolidate the formulation-specific chain: external physicochemical characterization of Terpenolol and targeted in vitro biophysical testing using an appropriate heterologous cellular system, a defined synthetic lipid-bilayer model, or both, to distinguish formulation-specific membrane effects from direct CBD–protein interactions.